Peak Bio, Inc. (PKBO)
USD 0.07
(204.35%)
USD 0.07
(204.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -4.75 Million | -7.48 Million | -8.86 Million | -2038.55 | -1044.59 |
| Net Income | -12.82 Million | -13.08 Million | -8.29 Million | -2458.29 | -1267.88 |
| Depreciation & Amortization | 311.11 Thousand | 786.48 Thousand | 176.64 Thousand | 39.27 | 8.37 |
| Deferred income taxes | - | -816.03 Billion | - | - | - |
| Stock-based compensation | 275.41 Thousand | 560.06 Thousand | 4890.00 | 929.78 | - |
| Change in working capital | 3.65 Million | 2.36 Million | 93.08 Thousand | -149.46 | -10.64 |
| Other non-cash items | 3.14 Million | 816.03 Billion | -846.27 Thousand | -399.85 | 225.57 |
| Investing Cash Flow | -100.23 | -142.24 Thousand | -9880.00 | -1697.82 | -488.39 |
| Investments in PPE | -2.72 | -142.24 Thousand | -9880.00 | -99.55 | -116.89 |
| Acquisitions | -97.51 | -106.81 | -330.61 | -1597.89 | -331.30 |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | -1.98 | -0.39 | -40.20 |
| Financing Cash Flow | 4.28 Million | 8.13 Million | 8.38 Million | 137.53 | 11.95 Thousand |
| Debt repayment | -3.43 Million | -1.6 Million | -1.99 Million | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 105.31 Thousand | 6.42 Million | 6.39 Million | - | - |
| Other Financing Activities | -289.58 Thousand | 107.75 Thousand | 1.99 Million | 137.53 | 11.95 Thousand |
| Accounts receivables | -68.16 | 99.51 | 25.25 | -132.45 | 4.22 |
| Accounts payables | 2.23 Million | 816.03 Thousand | -427.32 Thousand | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -14.33 | 1.55 Million | 520.41 Thousand | -17.01 | -14.86 |
| Cash at beginning of period | 894.59 Thousand | 442.47 Thousand | 409.86 Thousand | 11.04 Thousand | 586.57 |
| Cash at end of period | 441.64 Thousand | 894.59 Thousand | 442.47 Thousand | 7670.81 | 11.04 Thousand |
| Capital Expenditure | -2.72 | -142.24 Thousand | -9880.00 | -99.55 | -116.89 |
| Effect of forex changes on cash | 23.79 Thousand | -55.22 Thousand | 521.71 Thousand | - | - |
| Net cash flow / Change in cash | -452.94 Thousand | 452.11 Thousand | 32.61 Thousand | -3372.19 | 10.45 Thousand |
| Free Cash Flow | -4.75 Million | -7.62 Million | -8.87 Million | -2138.10 | -1161.49 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.07 Million | -2.43 Million | -525.44 Thousand | -12.82 Million | 410.58 Thousand | -5.94 Million |
| Depreciation & Amortization | 21.74 Thousand | 31.84 Thousand | 32.28 Thousand | 311.11 Thousand | 34.52 Thousand | 35.82 Thousand |
| Deferred income taxes | - | - | -5.35 Million | - | - | 2.27 Million |
| Stock-based compensation | 5.46 | 30.5 Thousand | -99.82 Thousand | 275.41 Thousand | 76.79 Thousand | 133.43 Thousand |
| Change in working capital | 647.09 Thousand | 888.78 Thousand | -555.46 Thousand | 3.65 Million | 1.32 Million | 1.31 Million |
| Other non-cash items | 264.13 Thousand | -48.81 Thousand | 748.66 Thousand | 3.14 Million | 1.15 Million | 954.14 Thousand |
| Investing Cash Flow | -908.41 | -188.45 | -36.54 | -100.23 | - | 483.24 Thousand |
| Investments in PPE | - | -3.12 | 2.67 | -2.72 | - | - |
| Acquisitions | -908.41 | -185.33 | -36.54 | -97.51 | - | -60.98 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -483.3 Thousand | - | - | - |
| Financing Cash Flow | 1 Million | 1.1 Million | 1.75 Million | 4.28 Million | 499.92 Thousand | 883.62 Thousand |
| Debt repayment | -1.32 Million | -1.42 Million | -990.59 Thousand | -3.43 Million | -125.8 Thousand | -2.19 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -105.31 Thousand | 105.31 Thousand | -294.68 Thousand | 400 Thousand |
| Other Financing Activities | -315.99 Thousand | -315.99 Thousand | 757.79 Thousand | -289.58 Thousand | -230.39 Thousand | 483.62 Thousand |
| Accounts receivables | -1.65 | -61.40 | -69.56 | -68.16 | 4.41 | -0.87 |
| Accounts payables | -295.58 Thousand | 166.76 Thousand | 136.63 Thousand | 2.23 Million | 580.99 Thousand | 279.29 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -52.07 | -7.05 | 32.08 | -14.33 | -35.02 | 1.03 Million |
| Cash at beginning of period | 128.61 Thousand | 441.64 Thousand | 154.43 Thousand | 894.59 Thousand | 274.36 Thousand | 624.17 Thousand |
| Cash at end of period | 295.77 Thousand | 128.61 Thousand | 441.64 Thousand | 441.64 Thousand | 154.43 Thousand | 274.36 Thousand |
| Capital Expenditure | - | -3.12 | 2.67 | -2.72 | - | - |
| Effect of forex changes on cash | -2445.00 | -3528.00 | 2505.00 | 23.79 Thousand | -3948.00 | 4.00 |
| Net cash flow / Change in cash | 167.16 Thousand | -313.03 Thousand | 287.21 Thousand | -452.94 Thousand | -119.93 Thousand | -349.8 Thousand |
| Free Cash Flow | -905.39 Thousand | -1.41 Million | -1.46 Million | -4.75 Million | -615.9 Thousand | -1.23 Million |
HOVVB
NICK
LIND
1911
CICN
6807